ADC Therapeutics SA (ADCT)

USD 1.21

(-0.82%)

Total Debt Summary of ADC Therapeutics SA

ADC Therapeutics SA's latest annual total debt in 2023 was 124.37 Million USD , up 5.97% from previous year.
ADC Therapeutics SA's latest quarterly total debt in 2024 Q2 was 124.39 Million USD , up 0.06% from previous quarter.
ADC Therapeutics SA reported annual total debt of 117.37 Million USD in 2022, up 15.36% from previous year.
ADC Therapeutics SA reported annual total debt of 101.75 Million USD in 2021, up 143.0% from previous year.
ADC Therapeutics SA reported quarterly total debt of 124.39 Million USD for 2024 Q2, up 0.06% from previous quarter.
ADC Therapeutics SA reported quarterly total debt of 123.52 Million USD for 2023 Q3, down -0.07% from previous quarter.

Annual Total Debt Chart of ADC Therapeutics SA (2023 - 2016)

Historical Annual Total Debt of ADC Therapeutics SA (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	124.37 Million USD	5.97%
2022	117.37 Million USD	15.36%
2021	101.75 Million USD	143.0%
2020	41.87 Million USD	732.3%
2019	5.03 Million USD	0.0%
2018	- USD	0.0%
2017	- USD	0.0%
2016	- USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	124.32 Million USD	-0.04%
2024 Q2	124.39 Million USD	0.06%
2023 Q3	123.52 Million USD	-0.07%
2023 Q1	122.94 Million USD	4.75%
2023 FY	124.37 Million USD	5.97%
2023 Q4	124.37 Million USD	0.69%
2023 Q2	123.61 Million USD	0.54%
2022 Q1	102.55 Million USD	0.79%
2022 FY	117.37 Million USD	15.36%
2022 Q4	117.37 Million USD	0.62%
2022 Q3	116.65 Million USD	12.91%
2022 Q2	103.31 Million USD	0.74%
2021 Q2	99.44 Million USD	108.04%
2021 Q3	100.64 Million USD	1.21%
2021 Q4	101.75 Million USD	1.1%
2021 FY	101.75 Million USD	143.0%
2021 Q1	47.79 Million USD	14.15%
2020 Q2	40.4 Million USD	0.0%
2020 Q3	40.08 Million USD	-0.78%
2020 Q1	- USD	-100.0%
2020 FY	41.87 Million USD	732.3%
2020 Q4	41.87 Million USD	4.46%
2019 Q2	5.37 Million USD	0.0%
2019 Q4	5.03 Million USD	0.0%
2019 FY	5.03 Million USD	0.0%
2019 Q1	- USD	0.0%
2018 Q1	- USD	0.0%
2018 Q3	- USD	0.0%
2018 Q4	- USD	0.0%
2018 FY	- USD	0.0%
2017 FY	- USD	0.0%
2016 FY	- USD	0.0%

Peer Total Debt Comparison of ADC Therapeutics SA

Name	Total Debt	Total Debt Difference
Alto Neuroscience, Inc.	151.46 Million USD	17.883%
Annovis Bio, Inc.	- USD	-Infinity%
Biohaven Pharmaceutical Holding Company Ltd.	30.87 Million USD	-302.814%
Ginkgo Bioworks Holdings, Inc.	241.76 Million USD	48.555%
Nuvation Bio Inc.	4 Million USD	-3003.994%
Nuvation Bio Inc.	4 Million USD	-3003.994%
Arcus Biosciences, Inc.	11 Million USD	-1030.7%
Zymeworks Inc.	26.72 Million USD	-365.448%